ABG
LEGN icon

Ally Bridge Group’s Legend Biotech LEGN Stock Holding History

Ally Bridge Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-195,000
Closed -$8.64M – 33
2024
Q2 		$8.64M Buy
+195,000
New +$9M 5.15% 6

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Ally Bridge Group's LEGN Position: Q3 2024 in Review

Ally Bridge Group sold out of Legend Biotech (LEGN) in Q3 2024, closing a stake of 195,000 shares — an estimated $8.64M sold.

Ally Bridge Group first reported a position in LEGN in Q2 2024 and held it in 1 quarter. The position peaked at $8.64M in Q2 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q3 2024.

  • Ally Bridge Group reported no remaining Legend Biotech position as of Q3 2024 after selling out during the quarter.
  • Ally Bridge Group sold 195,000 Legend Biotech shares in Q3 2024, an estimated $8.64M.
  • Ally Bridge Group first reported a position in Legend Biotech in Q2 2024 and held it in 1 quarter.
  • Ally Bridge Group's Legend Biotech position peaked at $8.64M in Q2 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2024.

Based on Ally Bridge Group's 13F filing for Q3 2024, filed 14 Nov 2024.